SlideShare a Scribd company logo
1 of 21
[object Object],[object Object],[object Object],[object Object],[object Object],Novel Tyrosine Kinase Inhibitors for  Ovarian Cancer Experimental Therapeutics Department Dr. Gabriel Lopez-Berestein,  MD
Outline
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]
Focal Adhesion Kinase ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Focal Adhesion Kinase
Ovarian Cancer Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New FAK Inhibitors ,[object Object],[object Object],JAK2-10 FAK ATP Binding Pocket
Hypothesis   JAK2-10 , inhibitor of JAK, also inhibits FAK activity.
Aim  To determine whether  JAK2-10  inhibits FAK activation in SKOV3 ovarian cancer cells .
Methods ,[object Object],[object Object],NT Treated 72 -hr ,[object Object],24- hr 48 -hr 24-hr  48-hr  72-hr
[object Object],[object Object],Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],From Molecular Cell Biology by Harvey Lodish et al. Credit: NIAID
-  +  -  +  -  + 24-hr 48-hr 72-hr Tota l FAK β-Actin Results (-)     untreated (+)     treated   2.5X10 4 cells/mL ,[object Object],-  +  -  +  -  + 24-hr 48-hr 72-hr pFAK β-Actin 5μM  JAK2-10 5μM JAK2-10 SKOV3 Cells
Methods B  NT  5  10 μM  JAK2-10 ,[object Object],After 72-hr
Results ,[object Object],Dose (μM) % Growth
Conclusions & Ongoing Work ,[object Object],[object Object],[object Object],[object Object],[object Object]
New FAK Inhibitors TAE226 ME-TAE226
Synthesis ,[object Object]
Future Directions ,[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thanks!!!

More Related Content

What's hot

TYROSINE KINASE INHIBITORS
TYROSINE KINASE INHIBITORSTYROSINE KINASE INHIBITORS
TYROSINE KINASE INHIBITORSyerroju vijay
 
mTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasemTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasedgotto
 
AKT/PKB SIGNALING PATHWAY
AKT/PKB SIGNALING PATHWAYAKT/PKB SIGNALING PATHWAY
AKT/PKB SIGNALING PATHWAYDharavath Anil
 
Portfolio of Past Research
Portfolio of Past ResearchPortfolio of Past Research
Portfolio of Past Researchnishmpatel
 
Effectiveness of Resveratrol on Metastasis: A Review
Effectiveness of Resveratrol on Metastasis: A ReviewEffectiveness of Resveratrol on Metastasis: A Review
Effectiveness of Resveratrol on Metastasis: A Reviewiosrphr_editor
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseGedion Yilma
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...dgotto
 
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...Nisha Rizvi
 
Epidermal growth factor(egf)
Epidermal growth factor(egf)Epidermal growth factor(egf)
Epidermal growth factor(egf).Jayanta Saha
 
Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .heenakazi4
 
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidSaris Arango
 
Targeted therapy anticancer drugs
Targeted therapy anticancer drugsTargeted therapy anticancer drugs
Targeted therapy anticancer drugsAbarna Ravi
 
Janus kinase inhibitors
Janus kinase inhibitors Janus kinase inhibitors
Janus kinase inhibitors Rajesh Boini
 
Genetic polymorphism in drug transport
Genetic polymorphism in drug transportGenetic polymorphism in drug transport
Genetic polymorphism in drug transportVineetha Menon
 

What's hot (20)

TYROSINE KINASE INHIBITORS
TYROSINE KINASE INHIBITORSTYROSINE KINASE INHIBITORS
TYROSINE KINASE INHIBITORS
 
mTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasemTOR: growth regulator involved in disease
mTOR: growth regulator involved in disease
 
pI3K pathway
pI3K pathwaypI3K pathway
pI3K pathway
 
AKT/PKB SIGNALING PATHWAY
AKT/PKB SIGNALING PATHWAYAKT/PKB SIGNALING PATHWAY
AKT/PKB SIGNALING PATHWAY
 
Portfolio of Past Research
Portfolio of Past ResearchPortfolio of Past Research
Portfolio of Past Research
 
Effectiveness of Resveratrol on Metastasis: A Review
Effectiveness of Resveratrol on Metastasis: A ReviewEffectiveness of Resveratrol on Metastasis: A Review
Effectiveness of Resveratrol on Metastasis: A Review
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinase
 
Janus kinase inhibitors
Janus kinase inhibitorsJanus kinase inhibitors
Janus kinase inhibitors
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
 
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...
JC Fall 2009-Role of TNFalpha-Converting Enzyme (TACE) Inhibition on Amyloid ...
 
Tofacitinib
TofacitinibTofacitinib
Tofacitinib
 
Presentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolismPresentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolism
 
Epidermal growth factor(egf)
Epidermal growth factor(egf)Epidermal growth factor(egf)
Epidermal growth factor(egf)
 
Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .
 
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid
 
Akt protein kinase b
Akt protein kinase bAkt protein kinase b
Akt protein kinase b
 
Targeted therapy anticancer drugs
Targeted therapy anticancer drugsTargeted therapy anticancer drugs
Targeted therapy anticancer drugs
 
Jak stat
Jak statJak stat
Jak stat
 
Janus kinase inhibitors
Janus kinase inhibitors Janus kinase inhibitors
Janus kinase inhibitors
 
Genetic polymorphism in drug transport
Genetic polymorphism in drug transportGenetic polymorphism in drug transport
Genetic polymorphism in drug transport
 

Viewers also liked

Tyrosine kinase inhibitors market & pipeline insight 2015
Tyrosine kinase inhibitors market & pipeline insight 2015Tyrosine kinase inhibitors market & pipeline insight 2015
Tyrosine kinase inhibitors market & pipeline insight 2015Rajesh Sarma
 
Cdk inhibitors as new target for cancer treatment.
Cdk inhibitors as new target for cancer treatment.Cdk inhibitors as new target for cancer treatment.
Cdk inhibitors as new target for cancer treatment.saraswathi rajakumar
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationBrazilPharmaNews.com
 
Akt (protein kinase)
Akt (protein kinase)Akt (protein kinase)
Akt (protein kinase)Amy Mehaboob
 
Oral tyrosine kinase inhibitors
Oral tyrosine kinase inhibitorsOral tyrosine kinase inhibitors
Oral tyrosine kinase inhibitorsSneha George
 
Cancer Chemotherapies Final
Cancer Chemotherapies FinalCancer Chemotherapies Final
Cancer Chemotherapies Finalluisa3001
 

Viewers also liked (6)

Tyrosine kinase inhibitors market & pipeline insight 2015
Tyrosine kinase inhibitors market & pipeline insight 2015Tyrosine kinase inhibitors market & pipeline insight 2015
Tyrosine kinase inhibitors market & pipeline insight 2015
 
Cdk inhibitors as new target for cancer treatment.
Cdk inhibitors as new target for cancer treatment.Cdk inhibitors as new target for cancer treatment.
Cdk inhibitors as new target for cancer treatment.
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology Presentation
 
Akt (protein kinase)
Akt (protein kinase)Akt (protein kinase)
Akt (protein kinase)
 
Oral tyrosine kinase inhibitors
Oral tyrosine kinase inhibitorsOral tyrosine kinase inhibitors
Oral tyrosine kinase inhibitors
 
Cancer Chemotherapies Final
Cancer Chemotherapies FinalCancer Chemotherapies Final
Cancer Chemotherapies Final
 

Similar to Novel Tyrosine Kinase Inhibitors for Ovarian Cancer

Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas AdenocarcinomaUpdate on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas AdenocarcinomaOSUCCC - James
 
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MDTargeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MDMelanoma Research Foundation
 
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...Fight Colorectal Cancer
 
RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1Korry Wirth
 
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...Dr. Martin Hager, MBA
 
Innovative clinical trial designs
Innovative clinical trial designs Innovative clinical trial designs
Innovative clinical trial designs Emad Shash
 
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...kphodel
 
Report Back from SGO: What's the Latest in Ovarian Cancer?
Report Back from SGO: What's the Latest in Ovarian Cancer?Report Back from SGO: What's the Latest in Ovarian Cancer?
Report Back from SGO: What's the Latest in Ovarian Cancer?bkling
 
Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010FilippaP
 
acs.jmedchem.5b00495
acs.jmedchem.5b00495acs.jmedchem.5b00495
acs.jmedchem.5b00495Justin Murray
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022Duke Heart
 
PROTAC Technology: An Effective Targeted Protein Degrader.pdf
PROTAC Technology: An Effective Targeted Protein Degrader.pdfPROTAC Technology: An Effective Targeted Protein Degrader.pdf
PROTAC Technology: An Effective Targeted Protein Degrader.pdfDoriaFang
 
Progress Toward Topical Therapy of AMD
Progress Toward Topical Therapy of AMDProgress Toward Topical Therapy of AMD
Progress Toward Topical Therapy of AMDRick Trevino
 
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásico
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásicoActualización en el abordaje terapéutico ante un cáncer colorrectal metastásico
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásicoMauricio Lema
 

Similar to Novel Tyrosine Kinase Inhibitors for Ovarian Cancer (20)

targeted therapy
targeted therapytargeted therapy
targeted therapy
 
Osp2 brennan SGC
Osp2 brennan SGCOsp2 brennan SGC
Osp2 brennan SGC
 
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas AdenocarcinomaUpdate on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
 
Osu lesko 6 oct final
Osu lesko 6 oct finalOsu lesko 6 oct final
Osu lesko 6 oct final
 
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MDTargeted Therapy for Uveal Melanoma - Richard Carvajal, MD
Targeted Therapy for Uveal Melanoma - Richard Carvajal, MD
 
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO co...
 
target identefication
target identeficationtarget identefication
target identefication
 
RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1RoswellResearchPoster2015-ver2smaller-1
RoswellResearchPoster2015-ver2smaller-1
 
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...
Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Cli...
 
Innovative clinical trial designs
Innovative clinical trial designs Innovative clinical trial designs
Innovative clinical trial designs
 
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...
Mu anti cancer therapeutics - novel targets in the cholesterol biosynthetic p...
 
Report Back from SGO: What's the Latest in Ovarian Cancer?
Report Back from SGO: What's the Latest in Ovarian Cancer?Report Back from SGO: What's the Latest in Ovarian Cancer?
Report Back from SGO: What's the Latest in Ovarian Cancer?
 
Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010
 
acs.jmedchem.5b00495
acs.jmedchem.5b00495acs.jmedchem.5b00495
acs.jmedchem.5b00495
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022
 
PROTAC Technology: An Effective Targeted Protein Degrader.pdf
PROTAC Technology: An Effective Targeted Protein Degrader.pdfPROTAC Technology: An Effective Targeted Protein Degrader.pdf
PROTAC Technology: An Effective Targeted Protein Degrader.pdf
 
article
articlearticle
article
 
Progress Toward Topical Therapy of AMD
Progress Toward Topical Therapy of AMDProgress Toward Topical Therapy of AMD
Progress Toward Topical Therapy of AMD
 
Mab vax presentation_april 2017
Mab vax  presentation_april 2017 Mab vax  presentation_april 2017
Mab vax presentation_april 2017
 
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásico
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásicoActualización en el abordaje terapéutico ante un cáncer colorrectal metastásico
Actualización en el abordaje terapéutico ante un cáncer colorrectal metastásico
 

More from Zuleika86

BioMinds Poster!!!!!!!!
BioMinds Poster!!!!!!!!BioMinds Poster!!!!!!!!
BioMinds Poster!!!!!!!!Zuleika86
 
Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Zuleika86
 
Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Zuleika86
 
Resultados Finales Agosto-Diciembre 2008!!!
Resultados Finales Agosto-Diciembre 2008!!!Resultados Finales Agosto-Diciembre 2008!!!
Resultados Finales Agosto-Diciembre 2008!!!Zuleika86
 
Metagenómica y sus Aplicaciones Industriales
Metagenómica y sus Aplicaciones IndustrialesMetagenómica y sus Aplicaciones Industriales
Metagenómica y sus Aplicaciones IndustrialesZuleika86
 
Metagenomics and Industrial Application
Metagenomics and Industrial ApplicationMetagenomics and Industrial Application
Metagenomics and Industrial ApplicationZuleika86
 
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!Bibliotecas Metagenómicas de Bajo Peso Molecular!!!
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!Zuleika86
 
Cloning the Soil Metagenome
Cloning the Soil MetagenomeCloning the Soil Metagenome
Cloning the Soil MetagenomeZuleika86
 
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...Zuleika86
 

More from Zuleika86 (9)

BioMinds Poster!!!!!!!!
BioMinds Poster!!!!!!!!BioMinds Poster!!!!!!!!
BioMinds Poster!!!!!!!!
 
Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...
 
Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...Functional genomic and culture independent approaches to search for protease ...
Functional genomic and culture independent approaches to search for protease ...
 
Resultados Finales Agosto-Diciembre 2008!!!
Resultados Finales Agosto-Diciembre 2008!!!Resultados Finales Agosto-Diciembre 2008!!!
Resultados Finales Agosto-Diciembre 2008!!!
 
Metagenómica y sus Aplicaciones Industriales
Metagenómica y sus Aplicaciones IndustrialesMetagenómica y sus Aplicaciones Industriales
Metagenómica y sus Aplicaciones Industriales
 
Metagenomics and Industrial Application
Metagenomics and Industrial ApplicationMetagenomics and Industrial Application
Metagenomics and Industrial Application
 
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!Bibliotecas Metagenómicas de Bajo Peso Molecular!!!
Bibliotecas Metagenómicas de Bajo Peso Molecular!!!
 
Cloning the Soil Metagenome
Cloning the Soil MetagenomeCloning the Soil Metagenome
Cloning the Soil Metagenome
 
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...
Construcción de Bibliotecas Metagenómicas de Bajo Peso Molecular de Bosques e...
 

Recently uploaded

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesShubhangi Sonawane
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 

Recently uploaded (20)

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 

Novel Tyrosine Kinase Inhibitors for Ovarian Cancer

  • 1.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. Hypothesis JAK2-10 , inhibitor of JAK, also inhibits FAK activity.
  • 9. Aim To determine whether JAK2-10 inhibits FAK activation in SKOV3 ovarian cancer cells .
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. New FAK Inhibitors TAE226 ME-TAE226
  • 17.
  • 18.
  • 19.
  • 20.